GRDX - Entero Therapeutics, Inc.
2.42
-0.370 -15.289%
Share volume: 203,774
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$2.79
-0.37
-0.13%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 10-21-2024 | 11-13-2024 | 05-15-2025 | 08-14-2025 | 11-19-2025 | |
| Assets | |||||||
| Total Assets | 91.134 M | 86.287 M | 85.821 M | 85.204 M | 85.059 M | 135.370 M | |
| Current Assets | 7.490 M | 84.387 M | 83.842 M | 83.463 M | 83.319 M | 87.699 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.522 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.432 M | 662.479 K | 366.788 K | 59.352 K | 4.474 K | 2.517 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 25.749 K | 1.335 K | 0.000 | 0.000 | 0.000 | 27.520 K | |
| Other Assets | 83.618 M | 1.878 M | 1.957 M | 1.733 M | 1.733 M | 47.644 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 91.134 M | 86.287 M | 85.821 M | 85.204 M | 85.059 M | 135.370 M | |
| Total liabilities | 13.270 M | 15.486 M | 15.771 M | 28.740 M | 29.676 M | 45.808 M | |
| Total current liabilities | 6.173 M | 15.385 M | 15.690 M | 28.740 M | 29.676 M | 33.516 M | |
| Accounts Payable | 1.997 M | 2.014 M | 2.215 M | 2.850 M | 3.298 M | 4.973 M | |
| Other liabilities | 127.592 K | 101.035 K | 80.213 K | 0.000 | 0.000 | 12.292 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.398 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 127.592 K | 101.035 K | 80.213 K | 0.000 | 0.000 | 12.292 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 16.183 M | 9.121 M | 8.369 M | -5.218 M | -6.298 M | 22.594 M | |
| Common stock | 194.944 M | 196.689 M | 198.519 M | 198.430 M | 198.348 M | 228.393 M | |
| Retained earnings | -178.761 M | -187.569 M | -190.150 M | -203.648 M | -204.646 M | -205.799 M |